Mark S. Baker

8.8k total citations
156 papers, 5.6k citations indexed

About

Mark S. Baker is a scholar working on Molecular Biology, Spectroscopy and Cancer Research. According to data from OpenAlex, Mark S. Baker has authored 156 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 40 papers in Spectroscopy and 38 papers in Cancer Research. Recurrent topics in Mark S. Baker's work include Advanced Proteomics Techniques and Applications (40 papers), Protease and Inhibitor Mechanisms (33 papers) and Cell Adhesion Molecules Research (19 papers). Mark S. Baker is often cited by papers focused on Advanced Proteomics Techniques and Applications (40 papers), Protease and Inhibitor Mechanisms (33 papers) and Cell Adhesion Molecules Research (19 papers). Mark S. Baker collaborates with scholars based in Australia, United States and Switzerland. Mark S. Baker's co-authors include Abidali Mohamedali, W F Doe, Gregory E. Rice, Janusz M. Gebicki, EK Kruithof, Mark P. Molloy, S J McKenzie, Gary D. Buffinton, Ewa M. Goldys and Gilbert S. Omenn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mark S. Baker

151 papers receiving 5.4k citations

Peers

Countries citing papers authored by Mark S. Baker

Since Specialization

Citations

This map shows the geographic impact of Mark S. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Baker more than expected).

Fields of papers citing papers by Mark S. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Baker. The network helps show where Mark S. Baker may publish in the future.

Co-authorship network of co-authors of Mark S. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Baker. A scholar is included among the top collaborators of Mark S. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Baker. Mark S. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Proteomic Examination of Plasma Extracellular Vesicles Across Colorectal Cancer Stages Uncovers Biological Insights That Potentially Improve Prognosis 2024 ·Cancers ·Abidali Mohamedali, Benjamin Heng, Ardeshir Amirkhani, (unknown), David Cantor, (unknown), Joo‐Shik Shin, Michael J. Solomon, Gilles J. Guillemin, Mark S. Baker, Seong Beom Ahn	2
2	The Low-Abundance Plasma Proteome Reveals Differentially Abundant Proteins Associated with Breast Implant Capsular Contracture: A Pilot Study 2024 ·Proteomes ·(unknown), Ardeshir Amirkhani, (unknown), Seong Beom Ahn, Anand K. Deva, Mark S. Baker, Karen Vickery, Honghua Hu	1
3	Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma 2023 ·Molecular Therapy ·(unknown), Rashi Rajput, (unknown), (unknown), Mehdi Mirzaei, Devaraj Basavarajappa, Veer Bala Gupta, (unknown), Samridhi Sharma, Yuyi You, Giovanna Galliciotti, Ghasem Hosseini Salekdeh, Mark S. Baker, Stuart L. Graham, Vivek Gupta	18
4	Use of a Recombinant Biomarker Protein DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins 2021 ·Journal of Proteome Research ·Seong Beom Ahn, Karthik Shantharam Kamath, Abidali Mohamedali, (unknown), Jemma Wu, Dana Pascovici, Subash Adhikari, (unknown), Gilles J. Guillemin, Matthew J. McKay, Edouard C. Nice, Mark S. Baker	10
5	Role of Multiomics Data to Understand Host–Pathogen Interactions in COVID-19 Pathogenesis 2021 ·Journal of Proteome Research ·(unknown), Arup Acharjee, Amrita Mukherjee, Mark S. Baker, Sanjeeva Srivastava	23
6	Research on the Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, According to the HUPO Human Proteome Project 2020 ·Journal of Proteome Research ·Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, Ileana M. Cristea, Fernando J. Corrales, Cecilia Lindskog, Young‐Ki Paik, Jennifer E. Van Eyk, Siqi Liu, Stephen R. Pennington, M Snyder, Mark S. Baker, Nuno Bandeira, Ruedi Aebersold, Robert L. Moritz, Eric W. Deutsch	30
7	Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 3.0 2019 ·Journal of Proteome Research ·Eric W. Deutsch, Lydie Lane, Christopher M. Overall, Nuno Bandeira, Mark S. Baker, Charles Pineau, Robert L. Moritz, Fernando J. Corrales, Sandra Orchard, Jennifer E. Van Eyk, Young‐Ki Paik, Susan T. Weintraub, Yves Vandenbrouck, Gilbert S. Omenn	85
8	Progress on Identifying and Characterizing the Human Proteome: 2019 Metrics from the HUPO Human Proteome Project 2019 ·Journal of Proteome Research ·Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, Fernando J. Corrales, Jochen M. Schwenk, Young‐Ki Paik, Jennifer E. Van Eyk, Siqi Liu, Stephen R. Pennington, M Snyder, Mark S. Baker, Eric W. Deutsch	30
9	Tissue and plasma proteomics for early stage cancer detection 2018 ·Molecular Omics ·Liyuan Peng, David Cantor, Canhua Huang, Kui Wang, Mark S. Baker, Edouard C. Nice	27
10	A Transferrin Triggered Pathway for Highly Targeted Delivery of Graphene‐Based Nanodrugs to Treat Choroidal Melanoma 2018 ·Advanced Healthcare Materials ·Bingxin Zhao, (unknown), Mimi Lin, (unknown), Suyan Shan, Tom Lawson, Lu Yan, Wenjing Zhang, Bingyang Shi, Shulei Chou, Mark S. Baker, Yong Liu	16
11	A Systematic Bioinformatics Approach to Identify High Quality Mass Spectrometry Data and Functionally Annotate Proteins and Proteomes 2016 ·Methods in molecular biology ·(unknown), Abidali Mohamedali, Seong Beom Ahn, (unknown), Mark S. Baker, Shoba Ranganathan	1
12	Is isolation of comprehensive human plasma peptidomes an achievable quest? 2015 ·Journal of Proteomics ·Sadia Mahboob, Abidali Mohamedali, Seong Beom Ahn, Peter Schulz‐Knappe, E.C. Nice, Mark S. Baker	32
13	Epithelial and Stromal Cell Urokinase Plasminogen Activator Receptor Expression Differentially Correlates with Survival in Rectal Cancer Stages B and C Patients 2015 ·PLoS ONE ·Seong Beom Ahn, Charles Chan, Owen F. Dent, Abidali Mohamedali, Sun Young Kwun, Candice Clarke, Julie Fletcher, Pierre H. Chapuis, Edouard C. Nice, Mark S. Baker	13
14	A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking 2014 ·Journal of Structural Biology ·(unknown), (unknown), (unknown), Seong Beom Ahn, Mark S. Baker, Shoba Ranganathan	12
15	Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQmass spectrometry 2011 ·Molecular BioSystems ·Lucy Jankova, Charles Chan, Caroline Fung, Xiaomin Song, Sun Young Kwun, Mark J. Cowley, Warren Kaplan, Owen F. Dent, E. L. Bokey, Pierre H. Chapuis, Mark S. Baker, Graham Robertson, Stephen Clarke, Mark P. Molloy	27
16	Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade 2002 ·Carcinogenesis ·Nuzhat Ahmed, (unknown), (unknown), Padma Murthi, Michael Quinn, Gregory E. Rice, Michael Agrez, Samuel C. Mok, Mark S. Baker	111
17	Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes 2000 ·Journal of Cellular Physiology ·(unknown), (unknown), Mark S. Baker, Pamela J. Jensen	20
18	Topological localization of plasminogen activator inhibitor type 2 2000 ·Cytometry ·Michael Liew, Virginia McPhun, Mark S. Baker	2
19	The oxidant hypochlorite (OCl−), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate 1991 ·Free Radical Biology and Medicine ·(unknown), Mark S. Baker, Christopher J. Handley, Dennis A. Lowther	66
20	The inhibitory action of oxygen radical scavengers on proteinuria and glomerular heparan sulphate loss in the isolated perfused kidney. 1990 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Mark S. Baker, Lynette M. Pratt	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact